greeksoup/ stock research
Stock research / United States / ZVRA / Planned sales

Zevra Therapeutics, Inc. planned insider sales

In the last twelve months insiders at Zevra Therapeutics, Inc. filed 11 Form 144 notices of planned sales, 601,824 shares worth $6.0 million at the time of filing, from 9 sellers. The latest, filed 13 October 2026: Neil F McFarlane (director, officer), 20,000 shares worth $227,800, planned for around 12 October 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
13 October 2026Neil F McFarlaneDirector, Officer20,000$227,80012 October 202620,000 shares from 12 October 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
14 August 2026Rahsaan ThompsonOfficer, Secretary42,666$477,00614 August 202642,666 shares from 14 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
8 July 2026John BodeDirector10,516$156,1638 July 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
11 May 2026Rahsaan ThompsonOfficer, Chief Legal & Compliance / Secretary36,351$404,58711 May 202636,351 shares from 11 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
16 March 2026Raymond L CliftonOfficer345,428$3.4 million16 March 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesPreviously Exercised Options; Restricted stock vesting under a registered planForm 144
2 February 2026Neil F McFarlaneDirector, Officer105,625$950,6252 February 2026105,625 shares from 2 February 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
30 January 2026Rahsaan ThompsonOfficer, Secretary4,080$36,14930 January 20264,080 shares from 30 January 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
30 January 2026Adrian QuartelOfficer4,533$40,16230 January 20264,533 shares from 30 January 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
30 January 2026Timothy SangiovanniOfficer4,750$42,08530 January 20264,750 shares from 30 January 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
30 January 2026Joshua SchaferOfficer13,875$122,93230 January 202613,875 shares from 30 January 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
30 January 2026R LaDuane CliftonFormer CFO & Treasurer14,000$124,04030 January 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?